MacroGenics, Inc. (FRA:M55)
Germany · Delayed Price · Currency is EUR 1.254
+0.001 (0.08%)
At close: Nov 28, 2025
MacroGenics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 127.63 | 149.96 | 58.75 | 151.94 | 77.45 | 104.88 | Upgrade | |
Revenue Growth (YoY) | -9.70% | 155.26% | -61.33% | 96.19% | -26.16% | 63.40% | Upgrade |
Cost of Revenue | 183.47 | 189.49 | 174.81 | 214.41 | 217.23 | 193.2 | Upgrade |
Gross Profit | -55.85 | -39.53 | -116.06 | -62.47 | -139.78 | -88.32 | Upgrade |
Selling, General & Admin | 57.74 | 71.05 | 52.19 | 58.95 | 63.01 | 42.74 | Upgrade |
Operating Expenses | 57.74 | 71.05 | 52.19 | 58.95 | 63.01 | 42.74 | Upgrade |
Operating Income | -113.58 | -110.58 | -168.24 | -121.42 | -202.8 | -131.06 | Upgrade |
Interest Expense | -4.21 | -1.12 | -1.43 | - | - | - | Upgrade |
Interest & Investment Income | 6.71 | 9.42 | 9.69 | 1.66 | 0.68 | 0.8 | Upgrade |
Other Non Operating Income (Expenses) | - | - | 150.93 | - | - | 0.52 | Upgrade |
EBT Excluding Unusual Items | -111.09 | -102.27 | -9.06 | -119.76 | -202.12 | -129.74 | Upgrade |
Gain (Loss) on Sale of Assets | 36.25 | 36.25 | - | - | - | - | Upgrade |
Pretax Income | -74.84 | -66.02 | -9.06 | -119.76 | -202.12 | -129.74 | Upgrade |
Income Tax Expense | 1.05 | 0.94 | - | - | - | - | Upgrade |
Net Income | -75.89 | -66.97 | -9.06 | -119.76 | -202.12 | -129.74 | Upgrade |
Net Income to Common | -75.89 | -66.97 | -9.06 | -119.76 | -202.12 | -129.74 | Upgrade |
Shares Outstanding (Basic) | 63 | 63 | 62 | 61 | 60 | 52 | Upgrade |
Shares Outstanding (Diluted) | 63 | 63 | 62 | 61 | 60 | 52 | Upgrade |
Shares Change (YoY) | 0.95% | 1.12% | 0.81% | 2.48% | 14.31% | 9.07% | Upgrade |
EPS (Basic) | -1.20 | -1.07 | -0.15 | -1.95 | -3.37 | -2.47 | Upgrade |
EPS (Diluted) | -1.21 | -1.07 | -0.15 | -1.95 | -3.37 | -2.47 | Upgrade |
Free Cash Flow | -164.76 | -72.08 | -79.97 | -90.58 | -150.03 | -117.8 | Upgrade |
Free Cash Flow Per Share | -2.61 | -1.15 | -1.29 | -1.47 | -2.50 | -2.25 | Upgrade |
Gross Margin | -43.76% | -26.36% | -197.54% | -41.11% | -180.49% | -84.21% | Upgrade |
Operating Margin | -89.00% | -73.74% | -286.38% | -79.91% | -261.85% | -124.96% | Upgrade |
Profit Margin | -59.46% | -44.66% | -15.42% | -78.82% | -260.97% | -123.70% | Upgrade |
Free Cash Flow Margin | -129.09% | -48.07% | -136.12% | -59.62% | -193.72% | -112.32% | Upgrade |
EBITDA | -106.06 | -103.04 | -158.6 | -109.55 | -191.54 | -119.1 | Upgrade |
EBITDA Margin | -83.10% | -68.71% | -269.96% | -72.10% | -247.31% | -113.56% | Upgrade |
D&A For EBITDA | 7.52 | 7.54 | 9.65 | 11.87 | 11.26 | 11.96 | Upgrade |
EBIT | -113.58 | -110.58 | -168.24 | -121.42 | -202.8 | -131.06 | Upgrade |
EBIT Margin | -89.00% | -73.74% | -286.38% | -79.91% | -261.85% | -124.96% | Upgrade |
Revenue as Reported | 127.63 | 149.96 | 58.75 | 151.94 | 77.45 | 104.88 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.